Journal for ImmunoTherapy of Cancer (Nov 2023)
587 Nivolumab increased vaccine induced T-cell infiltration in Prostate cancer
- James L Gulley,
- Ravi Madan,
- Jennifer Marte,
- Fatima Karzai,
- Amy Hankin,
- Houssein Abdul Sater,
- Manuk Manukyan,
- William Dahut,
- Shania Bailey,
- Wiem Lassoued,
- Michell Manu,
- Peter Pinto,
- Daniel Burnett,
- Kenneth Canubas,
- Nikki William
Affiliations
- James L Gulley
- 4 National Cancer Institute, Bethesda, Maryland, USA
- Ravi Madan
- 1NIH, Bethesda, MD, USA
- Jennifer Marte
- Aff3 National Cancer Institute/Genitourinary Malignancies Branch Bethesda MD USA
- Fatima Karzai
- 1NCI, NIH, Bethesda, MD, USA
- Amy Hankin
- Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
- Houssein Abdul Sater
- 13National Cancer Institute, Bethesda, MD, USA
- Manuk Manukyan
- 2 Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA
- William Dahut
- 1NIH, Bethesda, MD, USA
- Shania Bailey
- 1NIH, Bethesda, MD, USA
- Wiem Lassoued
- 2NCI, Frederick, MD, USA
- Michell Manu
- 1NIH, Bethesda, MD, USA
- Peter Pinto
- 1NIH, Bethesda, MD, USA
- Daniel Burnett
- 2National Institutes of Health, Bethesda, MD, USA
- Kenneth Canubas
- 2National Institutes of Health, Bethesda, MD, USA
- Nikki William
- 2National Institutes of Health, Bethesda, MD, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0587
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.